Dogra, Tanya
Pelz, Lars
Boehme, Julia D.
Kuechler, Jan
Kershaw, Olivia
Marichal-Gallardo, Pavel
Baelkner, Maike
Hein, Marc D.
Gruber, Achim D.
Benndorf, Dirk
Genzel, Yvonne
Bruder, Dunja
Kupke, Sascha Y.
Reichl, Udo
Funding for this research was provided by:
Max Planck Institute for Dynamics of Complex Technical Systems (MPI Magdeburg)
Article History
Received: 21 August 2023
Accepted: 15 November 2023
First Online: 28 November 2023
Competing interests
: A patent to treat IAV infections with OP7 as an antiviral agent is pending. Patent holders are S.Y.K. and U.R. Another patent about treating coronavirus infection using DI244 and OP7 as antiviral agents is pending. Patent holders are S.Y.K., U.R., M.D.H., D.B. (Dunja Bruder). All other authors declare that they do not hold any competing interest.